Best chemotherapy treatment

PreclinicalSmall molecule

AAssistance Publique - Hôpitaux de Paris

Best chemotherapy treatment is one of 54 small molecule programs targeting Arterial Occlusion. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Arterial OcclusionActive, not recruiting

Acute Myeloid LeukemiaActive, not recruiting

Arterial OcclusionPreclinical

Active, not recruiting

Acute Myeloid LeukemiaPreclinical

Active, not recruiting

Competition

Competitive Landscape

235 competitors in Acute Myeloid Leukemia

#DrugCompanyPhaseTrials

Idamycin

Pfizer

Phase 3

60 2

Xospata

Astellas

Phase 3

24 3

Vepesid

AAvyxa

Phase 3

52 4

Cerubidine

HHikma Pharmaceuticals LLC

Phase 3

42 5

Mylotarg

WWyeth-Lederle Vaccines

Phase 3

38 6

Cerubidine

HHikma Pharmaceuticals LLC

Phase 3

32 7

Neupogen

EEastern Cooperative Oncology Group

Phase 3

30 8

Nexavar

Bayer

Phase 3

12 9

Cellcept

Roche

Phase 3

11 10

Cytoxan

BBaxter Healthcare Corporation

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

N/AActive, not recruiting

Acute Myeloid Leukemia

NCT04822766

Q4 2028

N/ANot yet recruiting

Basilar Artery Occlusion

NCT07046299

Clinical

Trials by Indication[1]

Basilar Artery Occlusion1 trial

Basilar Artery Occlusion Chinese Endovascular Trial in Patients With Large Core Infarct

Not yet recruiting·—·N/A·NCT07046299·314 enrolled

Arterial Occlusion1 trial

Evaluation of Mechanical Thrombectomy in Acute Ischemic Stroke Related to a Distal Arterial Occlusion

Unknown status·AAssistance Publique - Hôpitaux de Paris·N/A·NCT05030142·488 enrolled

Acute Myeloid Leukemia1 trial

A Study Comparing Allogeneic Hematopoietic Cell Transplantation Versus Best Available Standard of Care Therapy in Elderly Patients With Acute Myeloid Leukemia

Active, not recruiting·AAssistance Publique - Hôpitaux de Paris·N/A·NCT04822766·24 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Best chemotherapy treatment. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Best chemotherapy treatment compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Best chemotherapy treatment. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AAssistance Publique - Hôpitaux de Paris

Best chemotherapy treatment

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2027

Q4 2028

Trials by Indication[1]

Basilar Artery Occlusion1 trial

Arterial Occlusion1 trial

Acute Myeloid Leukemia1 trial

References

Drug Info

Quick Facts

Related News